A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system

• Principais autores: Mingdi Liu (Autor), Liting Gu (Autor), Yuning Zhang (Autor), Honglan Zhou (Autor), Yishu Wang (Autor), Zhi-Xiang Xu (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Mesalazine, a preparation of 5-aminosalicylic acid, is a medication widely used in clinical practice as a first-line therapy in the treatment of mild and moderate inflammatory bowel disease. However, the long-term safety of mesalazine in large sample population was unknown. The current s...